AKT1S1 and diabetic kidney disease: Recent study on diabetic nephropathy shows that Smad7 and AKT1 substrate 1 (PRAS40), a negative regulator of Tor complex 1 (TORC1), are potential targets of miR-21 (Dey et al., 2011; Zhong et al., 2013).